Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device.

Harshita Gupta, H P Gupta, Gupta HP, Urmila Singh, Singh U, Seema Sinha, Sinha S
Journal of the Indian Medical Association · 2007 · vol. 105(7) , pp. 380, 382–5 · PMID:18178990 · W2410837882
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

The laevonorgestrel intra-uterine system is a novel long-acting intra-uterine device offering contraception and benefits for menorrhagia, dysmenorrhea, fibroids, endometriosis, adenomyosis, and endometrial hyperplasia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Laevonorgestrel intra-uterine system is a new hormone releasing long acting intra-uterine device. Besides being used as long acting contraceptive, it has multiple non-contraceptive benefits. It is the best choice for young women suffering from menorrhagia who want contraception along with preservation of fertility and for premenopausal women who want to avoid surgery. Moreover, it has been reported to be useful in patients with dysmenorrhoea, fibroids, endometriosis and adenomyosis and endometrial hyperplasia.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosisdysmenorrhea

MeSH descriptors

Contraception Contraceptive Agents, Female Intrauterine Devices Levonorgestrel Menorrhagia Contraception Contraceptive Agents, Female Contraceptive Agents, Female Female Humans Levonorgestrel Levonorgestrel Menorrhagia

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0 · commercial use OK